TRIBGBP

Trinity Biotech Plc-spon Adr

-$1.9M

Net Activity

Institutions Holding

27

Popularity Rank

#6938

Avg Weight

0.06%

Total Value

$2.6M

Ownership Trend

27 institutions currently hold TRIBGBP, with 1 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q4 2023)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

1

Key Holders

View all 27 holding institutions

Quarterly Activity

Recent Activity

+$14.4K

Total Buy Value

$0.0

Total Sell Value

New buy1
Trim0
Add0
Sold out0

1

Net Buyers

0

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding TRINITY BIOTECH PLC-SPON ADR (TRIBGBP)?
Major stakeholders currently include Hunter Associates Investment Management LLC ($700.0K), Stonehill Capital Management LLC ($649.0K), Renaissance Technologies LLC ($581.0K). Based on the latest 13F filings, there are a total of 27 tracked investment funds and institutions maintaining positions in TRIBGBP.
What is the overall institutional sentiment toward TRIBGBP recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.9M, driven by 1 managers accumulating shares while 0 reduced their exposure.
Which institutions have been selling or reducing their TRIBGBP positions?
In the latest period, no tracked funds trimmed or exited their positions in TRIBGBP.
Are there any notable investors adding TRIBGBP to their portfolios?
Yes, buying activity remains notable. 1 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $14.4K.

Related Stocks